Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2015 Feb;49(1):29-39.
doi: 10.1007/s12160-014-9641-8.

Predictors of adherence to glaucoma treatment in a multisite study

Paul F Cook  1 , Sarah J Schmiege, Steven L Mansberger, Jeffrey Kammer, Timothy Fitzgerald, Malik Y Kahook
Affiliations
Multicenter Study

Predictors of adherence to glaucoma treatment in a multisite study

Paul F Cook et al. Ann Behav Med. 2015 Feb.

Abstract

Background: Poor adherence hinders glaucoma treatment. Studies have identified demographic and clinical predictors of adherence but fewer psychological variables.

Purpose: We examined predictors from four health behavior theories and past research.

Methods: In the baseline phase of a three-site adherence study, before any intervention, 201 participants used electronic Medication Event Monitoring System (MEMS) bottles to monitor eyedrop use for 2 months, and completed questionnaires including self-reported adherence.

Results: MEMS showed 79% adherence and self-report 94% (0.5-1.5 missed weekly doses), but they correlated only r(s) = 0.31. Self-efficacy, motivation, dose frequency, and nonminority race/ethnicity predicted 35% of variance in MEMS. Cues to action, self-efficacy, and intention predicted 20% of variance in self-reported adherence.

Conclusions: Self-efficacy, motivation, intention, cues to action, dose frequency, and race/ethnicity each independently predicted adherence. Predictors from all theories were supported in bivariate analyses, but additional study is needed. Researchers and clinicians should consider psychological predictors of adherence. (ClinicalTrials.gov ID# NCT01409421.).

PubMed Disclaimer

Conflict of interest statement

Drs. Schmiege, Mansberger, Kammer, and Fitzgerald declare that they have no other conflict of interest.

Figures

Figure 1
Figure 1
Median and Variability for Two Measures of Adherence
See this image and copyright information in PMC

Comment in

References

    1. Friedman DS, Wolfs RC, Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532–538. - PMC - PubMed
    1. Rossi GC, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2010;21:410–414. - PubMed
    1. Gordon ME, Kass MA. Validity of standard compliance measures in glaucoma compared with an electronic eyedrop monitor. In: Cramer JA, Spilker B, editors. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991. pp. 163–173.
    1. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the glaucoma adherence and persistency study (GAPS) Invest Ophthalmol Vis Sci. 2007;48:5052–5057. - PubMed
    1. Meichenbaum DC, Turk D. Facilitating Treatment Adherence: A Practitioner’s Guidebook. New York: Plenum Press; 1987.

Publication types

Associated data